ArticleMedical oncology (Northwood, London, England)2018

Predictive markers for efficacy of everolimus plus exemestane in patients with luminal HER2-negative metastatic breast cancer.

Misato Okazaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.